The global artificial insemination market was valued at around US$ 1.9 Billion at the end of 2021. The market is projected to register a 9.1% CAGR and top a valuation of US$ 4.5 Billion by 2032.
One of the significant factors shaping the market is the rising infertility rates, with a rise in public awareness of alternative reproductive treatments.
Artificial insemination is a method of assisted reproduction in which the semen is administered into the vagina, oviducts, or uterus of a female patient. Artificial insemination homologous (AIH) or artificial insemination donor semen (AID) procedures are used to do it swiftly and with little discomfort.
Self-insemination kits that can be used in the comfort of your home are now available on the market. Currently, artificial insemination is a popular procedure in animal breeding as well, aiding in effective breeding and the conservation of endangered species. Additionally, it reduces animal sterility caused by genital issues and the development of various diseases.
| Attributes | Details |
|---|---|
| Artificial Insemination Market Value in 2021 | US$ 1.9 Billion |
| Artificial Insemination Market Value in 2032 | US$ 4.5 Billion |
| Artificial Insemination Market CAGR (2022 to 2032) | 9.1% |
Infertility rates are rising globally as more individuals are suffering from conditions like Polycystic Ovary Syndrome (PCOS) and erectile dysfunction. Changes in lifestyle and the desire of more working women to have children later in life can be significant. Stress, alcohol usage, changes in diet and lifestyle, a decrease in sperm count and mobility, and other factors can all make it difficult for men to produce healthily. The persistent increase in male and female infertility is what fuels the artificial insemination market.
As more people become aware of assisted reproduction in developing countries, the market presents a number of potential options for the players as they provide patients with high-quality treatments and reasonably priced services. Government assistance for clinic expansion may also improve the job prospects for newcomers to the industry. The need for artificial insemination in domestic livestock is also being pushed by the expanding human population and the increased need for protein derived from animals. Additional contributing reasons include the expansion of the veterinary sector and rising healthcare expenditures for animals.
The artificial insemination market is broadly divided into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.
Europe is the major regional market because of declining fertility rates over the course of time. Delays in pregnancy and changes in lifestyle are a couple of the causes contributing to this decline.
The North American artificial insemination market is also expected to display lucrative growth in the projected years owing to the presence of well-established healthcare infrastructure and skilled professionals.
The East Asian region is predicted to show the fastest growth due to the increasing infertility rate and raising awareness about the available treatment options.
Vitrolife, Genea Limited, Rinovum Women's Health, Pride Angel, Hi-tech Solutions, Fujifilm Irvine Scientific, Kitazato Corporation, Rocket Medical Plc., Conceivex Inc., TenderNeeds Fertility LLC, Genus plc.
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 9.1% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2012 to 2021 |
| Forecast Period | 2022 to 2032 |
| Qualitative Units | Revenue in USD Billion, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segment Covered | Service Type, Donor Type, Service Provider, Region |
| Region Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC Countries, South Africa, Israel |
| Key Players | Vitrolife; Genea Limited; Rinovum Women's Health; Pride Angel; Hi-tech Solutions; Fujifilm Irvine Scientific; Kitazato Corporation; Rocket Medical Plc.; Conceivex Inc.; TenderNeeds Fertility LLC; Genus plc |
| Customization | Available Upon Request |
The global artificial insemination market is anticipated to register a CAGR of 9.1% during the forecast period.
The global artificial insemination market is projected to be about US$ 4.5 Billion by the end of the year 2032.
Explore Similar Insights
Artificial Insemination Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
